Elanco Animal Health

NYSE: ELAN · Real-Time Price · USD
17.95
-0.05 (-0.28%)
At close: Aug 15, 2025, 3:59 PM
17.96
0.08%
After-hours: Aug 15, 2025, 05:44 PM EDT

Elanco Animal Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
4.48B 4.43B 4.44B 4.45B 4.49B 4.37B 4.42B 4.37B 4.33B 4.45B 4.42B 4.54B 4.65B 4.75B 4.76B 4.79B 4.55B 3.86B
Cost of Revenue
2.16B 2.26B 2.27B 2.28B 2.14B 1.95B 1.93B 1.86B 1.85B 1.9B 1.91B 1.98B 2.01B 2.07B 2.13B 2.22B 2.16B 1.9B
Gross Profit
2.19B 2.04B 2.04B 2.17B 2.35B 2.41B 2.49B 2.51B 2.48B 2.55B 2.5B 2.57B 2.64B 2.67B 2.63B 2.57B 2.39B 1.95B
Operating Income
345M 239M 251M 219M 266M 204M 283M 313M 315M 397M 354M 282M 290M 275M 195M 154M 88.4M -12.4M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 100K 100K
Pretax Income
593M 536M 488M 412M -1.24B -1.29B -1.2B -1.16B -101M -40M -77M -110M -198M -416M -567M -764.1M -843.1M -684.2M
Net Income
434M 373M 338M 205M -1.25B -1.3B -1.23B -1.14B -97M -22M -74M -117M -172M -360M -472M -697.8M -728.8M -572M
Selling & General & Admin
1.36B 1.32B 1.31B 1.31B 1.3B 1.29B 1.28B 1.3B 1.28B 1.27B 1.26B 1.29B 1.33B 1.38B 1.4B 1.45B 1.38B 1.16B
Research & Development
354M 351M 344M 342M 341M 333M 327M 328M 320M 321M 321M 333M 349M 361M 369M 389.7M 383.8M 349.2M
Other Expenses
128M 126M -11M -45M -54M -75M 68M 232M 369M 525M 528M 401M 262M 132M 142M 155.6M 281.5M 326.4M
Operating Expenses
1.85B 1.8B 1.79B 1.92B 2.05B 2.17B 2.16B 2.16B 2.13B 2.12B 2.11B 2.16B 2.23B 2.28B 2.33B 2.42B 2.3B 1.97B
Interest Expense
192M 209M 235M 256M 270M 279M 277M 272M 260M 253M 241M 234M 234M 227M 236M 241.4M 229.5M 194.3M
Selling & Marketing Expenses
n/a n/a n/a 207M 207M 207M 207M 201M 201M 201M 201M 248M 248M 248M 248M 611M 611M 611M
Cost & Expenses
4.14B 4.19B 4.19B 4.2B 4.19B 4.13B 4.09B 4.03B 3.98B 4.01B 4.03B 4.14B 4.24B 4.36B 4.46B 4.64B 4.46B 3.87B
Income Tax Expense
159M 163M 150M 207M 11M 11M 36M -12M -4M -18M n/a 10M -23M -53M -95M -66.3M -114.3M -112.2M
Shares Outstanding (Basic)
496.6M 495.1M 494.4M 494.3M 494.2M 493.2M 492.8M 492.7M 492.6M 491.1M 488.5M 488.4M 488.4M 488M 487.4M 487.3M 487.3M 486.7M
Shares Outstanding (Diluted)
500.1M 499.1M 494.4M 497.7M 494.2M 496M 492.8M 492.7M 492.6M 492.8M 488.5M 488.4M 488.4M 492.2M 487.4M 487.3M 487.3M 486.7M
EPS (Basic)
0.88 0.76 0.68 0.41 -2.55 -2.65 -2.5 -2.32 -0.2 -0.04 -0.15 -0.25 -0.35 -0.74 -0.97 -1.43 -1.51 -1.21
EPS (Diluted)
0.86 0.74 0.67 0.40 -2.55 -2.65 -2.5 -2.32 -0.2 -0.04 -0.15 -0.25 -0.35 -0.74 -0.97 -1.43 -1.51 -1.21
EBITDA
1.44B 1.42B 1.46B 1.39B -247M -212M -117M -82M 987M 1.06B 1.02B 987M 870M 859M 800M 651.3M 522.7M 248.9M
EBIT
712M 745M 778M 723M -919M -957M -918M -881M 160M 218M 173M 136M 174M -55M -201M -397.9M -612.9M -489.1M
Depreciation & Amortization
495M 657M 662M 669M 672M 687M 694M 692M 686M 680M 683M 688M 691M 690M 716M 764.2M 727.2M 637.2M